<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">Drug Alcohol Depend</journal-id><journal-id journal-id-type="iso-abbrev">Drug Alcohol Depend</journal-id><journal-id journal-id-type="pmc-domain-id">319</journal-id><journal-id journal-id-type="pmc-domain">nihpa</journal-id><journal-title-group><journal-title>Drug and alcohol dependence</journal-title></journal-title-group><issn pub-type="ppub">0376-8716</issn><issn pub-type="epub">1879-0046</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>NIHPA Author Manuscripts</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC6312483</article-id><article-id pub-id-type="pmcid-ver">PMC6312483.1</article-id><article-id pub-id-type="pmcaid">6312483</article-id><article-id pub-id-type="pmcaiid">6312483</article-id><article-id pub-id-type="manuscript-id">NIHMS1513206</article-id><article-id pub-id-type="pmid">30469100</article-id><article-id pub-id-type="doi">10.1016/j.drugalcdep.2018.10.008</article-id><article-id pub-id-type="manuscript-id-alternative">NIHMS1513206</article-id><article-id pub-id-type="manuscript-id-alternative">NIHPA1513206</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Influence of comorbid drug use disorder on receipt of evidence-based treatment for alcohol use disorder among VA patients with alcohol use disorder and Hepatitis C and/or HIV</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Frost</surname><given-names initials="MC">Madeline C.</given-names></name><xref ref-type="aff" rid="A1">a</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Matson</surname><given-names initials="TE">Theresa E.</given-names></name><xref ref-type="aff" rid="A1">a</xref><xref ref-type="aff" rid="A2">b</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Tsui</surname><given-names initials="JI">Judith I.</given-names></name><xref ref-type="aff" rid="A3">c</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Williams</surname><given-names initials="EC">Emily C.</given-names></name><xref ref-type="aff" rid="A1">a</xref><xref ref-type="aff" rid="A4">d</xref></contrib></contrib-group><aff id="A1"><label>a</label>Health Services Research and Development (HSR&amp;D) Center of Innovation for Veteran-Centered and Value-Driven Care, Veterans Affairs (VA) Puget Sound Health Care System, 1660 South Columbian Way, Seattle WA 98108; <email>Tessa.E.Matson@kp.org</email>; <email>Madeline.Frost@va.gov</email>; <email>Emily.Williams3@va.gov</email></aff><aff id="A2"><label>b</label>Kaiser Permanente Washington Health Research Institute, 1730 Minor Ave, Seattle, WA 98101; <email>Tessa.E.Matson@kp.org</email></aff><aff id="A3"><label>c</label>Department of Medicine, University of Washington School of Medicine, 1959 NE Pacific St, Seattle, WA 98195; <email>tsuij@uw.edu</email></aff><aff id="A4"><label>d</label>Department of Health Services, University of Washington School of Public Health, 1959 NE Pacific St, Seattle, WA 98195; <email>Emily.Williams3@va.gov</email></aff><author-notes><corresp id="CR1"><bold>Correspondence</bold> Madeline C. Frost, MPH, VA Puget Sound Health Care System, 1660 South Columbian Way, Seattle, WA 98108, (206) 764-2822, <email>Madeline.Frost@va.gov</email></corresp><fn fn-type="con" id="FN1"><p id="P1">Contributors</p><p id="P2">Ms. Frost led data analysis, interpretation, and manuscript writing. Dr. Williams led the creation of the secondary dataset and provided mentorship for data analysis, interpretation and revision of the manuscript. Ms. Matson and Dr. Tsui contributed to interpretation of findings and revision of the manuscript. All authors contributed to and have approved the final manuscript.</p></fn><fn fn-type="COI-statement" id="FN2"><p id="P33">Conflict of Interest</p><p id="P34">The authors declare no conflicts of interest.</p></fn></author-notes><pub-date pub-type="epub"><day>30</day><month>10</month><year>2018</year></pub-date><pub-date pub-type="ppub"><day>01</day><month>1</month><year>2019</year></pub-date><volume>194</volume><issue-id pub-id-type="pmc-issue-id">326468</issue-id><fpage>288</fpage><lpage>295</lpage><pub-history><event event-type="nihms-submitted"><date><day>21</day><month>11</month><year>2018</year></date></event><event event-type="pmc-release"><date><day>01</day><month>01</month><year>2020</year></date></event><event event-type="pmc-live"><date><day>01</day><month>01</month><year>2020</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-06-18 14:25:28.847"><day>18</day><month>06</month><year>2024</year></date></event></pub-history><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-1513206.pdf"/><abstract id="ABS1"><sec id="S1"><title>Background:</title><p id="P3">Alcohol use is risky for patients with hepatitis C virus (HCV) and/or human immunodeficiency virus (HIV) infection, but alcohol use disorder (AUD) treatment is underutilized in these populations. Comorbid drug use disorders (DUD) are common, but their influence on AUD treatment receipt is understudied. We evaluated the association between DUD and AUD treatment receipt in two national samples of patients with AUD, those with HIV and those with HCV, in the U.S. Veterans Health Administration.</p></sec><sec id="S2"><title>Methods:</title><p id="P4">Samples included patients with AUD and HCV and/or HIV among positive alcohol screens (AUDIT-C&#8805;5) documented 10/01/09-5/30/13 in the national electronic health record. Poisson regression models estimated incidence rate ratios for receiving specialty treatment (stop codes) and pharmacotherapy (filled prescription for naltrexone, disulfiram, acamprosate, or topiramate) within 365 days of positive alcohol screening for patients with DUD versus those without. Models were clustered on patient and adjusted for potential confounders.</p></sec><sec id="S3"><title>Results:</title><p id="P5">Among 22,039 patients with HCV/AUD, 45.2% (N=9,964) had DUD, which was associated with receiving specialty treatment [adjusted incidence rate ratio: 1.89 (95% confidence interval 1.82-1.96)] and pharmacotherapy [aIRR: 1.50 (1.37-1.65)]. Among 1,834 patients with HIV/AUD, 56.9% (N=1,043) had DUD, which was associated with receiving specialty treatment [aIRR: 1.94 (1.68-2.24)], but not pharmacotherapy.</p></sec><sec id="S4"><title>Conclusions:</title><p id="P6">Rates of AUD treatment receipt among patients with AUD and HCV and/or HIV were low overall, but likelihood of treatment receipt was generally higher among those with comorbid DUD. Future research should investigate mechanisms underlying these associations, such as enhanced readiness for treatment or differential provider prescribing or referral practices.</p></sec></abstract><kwd-group><kwd>Alcohol</kwd><kwd>Alcohol Use Disorder</kwd><kwd>Treatment</kwd><kwd>Comorbidity</kwd><kwd>HCV</kwd><kwd>HIV</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>